ISZO Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NTP
Nam Tai Property Inc.
NTP
|
+$4.5M |
| 2 |
CBL
CBL Properties
CBL
|
+$3.79M |
| 3 |
Lifecore Biomedical
LFCR
|
+$2.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$64.4M |
| 2 |
NOTV
Inotiv
NOTV
|
+$28.4M |
| 3 |
XPEL
XPEL
|
+$7.09M |
| 4 |
Cryo-Cell International
CCEL
|
+$1.16M |
| 5 |
CO
Global Cord Blood Corporation
CO
|
+$4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 58.64% |
| 2 | Healthcare | 41.36% |
| 3 | Consumer Discretionary | 0% |
Similar funds
ISZO Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, ISZO Capital Management held 8 positions worth $84.3M, down 56% from $190M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
ISZO Capital Management withdrew a net $90M in Q1 2022, closing 3 positions and reducing 2 holdings. Its most notable exit was Avid Bioservices, Inc. Common Stock, an estimated $64.4M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 59% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, ISZO Capital Management opened a new position in CBL Properties worth $4.31M.
- ISZO Capital Management's largest Q1 2022 buy was CBL Properties: 131,100 shares worth $4.31M.
- ISZO Capital Management added most to Nam Tai Property Inc. in Q1 2022, an estimated $4.5M increase.
- ISZO Capital Management's biggest Q1 2022 reduction was Inotiv, cutting an estimated $28.4M.
- ISZO Capital Management fully exited Avid Bioservices, Inc. Common Stock in Q1 2022, selling an estimated $64.4M.
- ISZO Capital Management's ten largest holdings make up 100% of its $84.3M portfolio in Q1 2022.
- ISZO Capital Management opened 1 new position and closed 3 in Q1 2022.
- ISZO Capital Management's portfolio value fell 56% quarter-over-quarter to $84.3M.
Based on ISZO Capital Management's 13F filing for Q1 2022, filed 16 May 2022.